Ferdinandos Skoulidis, M.D.
NPI 1679957187ActiveIndividual· Internal Medicine, Medical Oncology· Houston, TX
Internal Medicine, Medical Oncology (M.D.) with Physicians Referral Service, practicing in Houston, Texas. Their prescriptions cost Medicare Part D more than their services did: $1,498,402 for 162 claims, against $24,738 paid for services in 2024. Merck Sharp & Dohme LLC was the largest of 13 companies reporting payments in 2025, $45,431 in all, mostly consulting fees.
Overview
| NPI | 1679957187 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jul 14, 2015 |
| Last updated in NPPES | Dec 23, 2015 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Medical Oncology Primary | 207RX0202X | 45126 | TX |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Practitioner - Medical Oncology (TX) |
|---|---|
| Accepts assignment | Yes (participating) |
Medicare services in 2024
| Medicare patients | 108 |
|---|---|
| Services billed | 299 across 14 procedure codes |
| Paid by Medicare | $24,738 |
Part D prescriptions in 2024
| Prescriptions (claims) | 162 · 167 30-day fills |
|---|---|
| Patients | 32 |
| Total drug cost | $1,498,402 |
| Generic share | 44% of claims |
Education and affiliations
| Graduation year | 2000 |
|---|---|
| Medicare specialty | Medical Oncology |
| Telehealth | Offers telehealth |
Medical group
- Physicians Referral ServiceHouston, TX · 2,765 clinicians
Industry payments (Open Payments)
- 2025$45,431 · 38 payments from 13 companies
- 2024$36,565 · 37 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Merck Sharp & Dohme LLC | $13,517 | 12 |
| Astrazeneca Pharmaceuticals LP | $7,636 | 6 |
| Eli Lilly and Company | $5,200 | 2 |
| F. Hoffmann-La Roche Ag | $4,650 | 4 |
| Genentech USA, Inc. | $3,878 | 3 |
What the 2025 payments were for
- Consulting Fee$42,457 · 15 payments
- Travel and Lodging$1,716 · 6 payments
- Food and Beverage$1,259 · 17 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Medical Oncology providers in Houston
- 1144581067
- 1659324093
- 1427067479
- 1023189685
- 1962419804
- 1134233224
- 1518227735
- 1205097599
- 1215123971
- 1285846790
- 1124107156
- 1518059898
All Internal Medicine, Medical Oncology providers in Texas →